Friday, Sep 18, 2026

"rsv-vax"

Report predicts RSV vaccine market to exceed $9 billion by 2029

Ahead of the impending RSV season in September, Moderna’s mRNA-1345 and AstraZeneca’s Beyfortus are also likely to stake a claim in the market.

Latest News

iPhone 18 series goes on sale in India, buyers queue up at Apple stores

1 minute ago
Tom Cruise says Taylor Swift schooled him about football

8 minutes ago
AI must stay under human control: Satya Nadella

8 minutes ago
New names and symbols for Mamata and Ritabrata-led Trinamool factions likely to come out today

25 minutes ago
Tata Group shares fall up to 8 pc amid corporate feud over N Chandrasekaran

34 minutes ago
Rupee gains 16 paise to 95.73 against US dollar in early trade

43 minutes ago
Mayawati criticises 0.4pc UPI merchant fee, calls it ‘profiteering’

51 minutes ago
Sensex rises 260 points, Nifty gains 64 points in early trade

1 hour ago